Hongping Wu

Title: Innovative Contributions of Inventor Hongping Wu

Introduction

Hongping Wu is a notable inventor based in Shanghai, China. With a focus on advancements in biomedicine, Wu has made significant contributions to the field through his innovative patent applications. He holds two patents that showcase his expertise and creativity in developing novel solutions for medical applications.

Latest Patents

Wu's most recent patents include a "Killer cell capable of efficiently and stably expressing antibody, and uses thereof." This invention features a transgenic killer cell with a genome integrated with a coding sequence for a human Fc section antibody, or an expression cassette for chimeric antigen receptors or inhibitory/agonistic antibodies. The patent also encompasses a pharmaceutical composition that utilizes the transgenic killer cell, demonstrating Wu's commitment to enhancing therapeutic options in cancer treatment.

The second patent is a "Tumor tissue cryopreservation kit, tumor tissue resuscitation kit, and method of cryopreserving and/or resuscitating tumor tissue." This kit comprises a first solution that includes Dulbecco's Modified Eagle Medium (DMEM), dimethyl sulfoxide (DMSO), ethylene glycol (EG), and bovine serum albumin (BSA), among other components. The second solution also features DMEM, DMSO, and additional crucial substances to aid in cryopreserving and resuscitating tumor tissue. The kit is designed to enhance the viability of tumor tissues for research and therapeutic use, thus contributing to the advancement of cancer research.

Career Highlights

Throughout his career, Hongping Wu has been associated with reputable organizations such as Shanghai Celliver Biotechnology Inc. and Shanghai Cell Therapy Research Institute. His work in these institutions has allowed him to collaborate on pioneering research in cellular therapies and biotechnology, solidifying his reputation as a leading inventor in his field.

Collaborations

Wu has worked alongside talented individuals such as Min Zeng and Xu Zhou. Their collective expertise and focus on research have fostered an environment of innovation, contributing to Hongping Wu's success as an inventor in the biotechnology domain.

Conclusion

Hongping Wu's contributions to biomedicine through his patents demonstrate his inventive spirit and dedication to advancing healthcare technology. His work in developing transgenic cells and medical kits highlights the importance of innovation in tackling pressing medical challenges. As the field of biotechnology continues to evolve, Wu's inventions are set to play a crucial role in shaping future therapeutic strategies.